CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 8-K Event Results of operations
- 8-K Event Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Planned sale Chief Executive Officer sold 50,000 shares at an average $149.50 ($7,475,024)
- 144 Insider Sale of Securities
- 3 Insider Initial Statement of Ownership
- 144 Insider Sale of Securities
- 8-K Event Executive or director change · Other events
- 8-K Event Other events
- 4 Open-market sale Chief Executive Officer sold 50,000 shares at an average $167.36 ($8,368,017)
- 4 Gift Director gave 82,020 shares (gift)
- 144 Insider Sale of Securities
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Financial Officer sold 397 shares at $167.08 ($66,331)
- 144 Insider Sale of Securities
- 10-K Report Annual Report
- 8-K Event Results of operations · Other events
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
Page 22 of 64 · 1,278 filings